Nothing travels faster than the speed of light with the possible exception of bad news, which obeys its own special laws
Douglas Adams - Hitchhiker's Guide to the Galaxy
I find this quote from the Hitchhiker's Guide to be particularly apt when thinking about how the biotech sector operates in general, and especially when considering MannKind (NASDAQ:MNKD) and Prana Biotechnology (NASDAQ:PRAN) in particular. Namely, these two companies are somehow able to give investors bad news without it sinking into the collective mindset of the investing community - at least not yet.
Prana, for example, released negative results from their Phase 2 trial for Huntington's Disease yesterday, but the stock still exploded nearly 50% upwards at one...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|